Robertson Stephens Wealth Management’s Fidelity MSCI Consumer Discretionary Index ETF FDIS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.49M Buy
14,474
+716
+5% +$72.2K 0.04% 252
2026
Q1
$1.28M Buy
13,758
+328
+2% +$32.9K 0.04% 265
2025
Q4
$1.37M Buy
13,430
+9,878
+278% +$1M 0.04% 255
2025
Q3
$365K Sell
3,552
-561
-14% -$55.4K 0.01% 410
2025
Q2
$387K Sell
4,113
-159
-4% -$14K 0.01% 416
2025
Q1
$361K Sell
4,272
-978
-19% -$92K 0.01% 419
2024
Q4
$512K Sell
5,250
-208
-4% -$19.5K 0.02% 356
2024
Q3
$483K Sell
5,458
-1,723
-24% -$143K 0.02% 422
2024
Q2
$582K Buy
7,181
+3
+0% +$238 0.03% 310
2024
Q1
$592K Buy
+7,178
New +$568K 0.03% 314

Other funds holding FDIS

Robertson Stephens Wealth Management's FDIS Position: Q2 2026 in Review

Robertson Stephens Wealth Management increased its Fidelity MSCI Consumer Discretionary Index ETF (FDIS) stake by 5.2% in Q2 2026, buying an estimated $72.2K and bringing the position to 14,474 shares worth $1.49M. The position accounts for 0.04% of the portfolio, ranked #252.

Robertson Stephens Wealth Management first reported a position in FDIS in Q1 2024 and has held it in 10 quarters since. 237 funds tracked by Wall St. Rank hold FDIS as of Q2 2026.

  • Robertson Stephens Wealth Management held 14,474 shares of Fidelity MSCI Consumer Discretionary Index ETF worth $1.49M as of Q2 2026.
  • Robertson Stephens Wealth Management bought 716 Fidelity MSCI Consumer Discretionary Index ETF shares in Q2 2026, an estimated $72.2K.
  • Fidelity MSCI Consumer Discretionary Index ETF made up 0.04% of Robertson Stephens Wealth Management's portfolio in Q2 2026, its #252 holding.
  • Robertson Stephens Wealth Management first reported a position in Fidelity MSCI Consumer Discretionary Index ETF in Q1 2024 and has held it in 10 quarters since.
  • 237 funds tracked by Wall St. Rank held Fidelity MSCI Consumer Discretionary Index ETF as of Q2 2026.

Based on Robertson Stephens Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.